GRANULAR, EVIDENCE-BASED medicine, based on genomic information, matching drug choices, is an approaching tidal wave, driven by cutting medical costs. Most doctors have scant genetics in medical school, but know it will result in better outcomes. Thus, reducing the terabytes of data to consensus algorithms available on hand-held devices may bridge that shortfall. This is a significant opportunity for entrepreneurs, working with professional bodies of ”
“geneticists and physicians to transform Big Genetics Data into a friendly and useable form.